China Isotope & Radiation Corp.

As of June 30, 2026, China Isotope & Radiation Corp. carries a market capitalization of 594.97M, placing it among publicly traded companies globally. Its enterprise value stands at 1.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

China Isotope & Radiation Corp.'s next confirmed earnings release is scheduled for March 31, 2027.

As of June 30, 2026, China Isotope & Radiation Corp. has 319.87M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, China Isotope & Radiation Corp. maintains a current ratio of 1.80, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

These figures are as of the close on October 22, 2026. The 50-day moving average sits at 1.48, while the 200-day moving average is 1.87.

As of June 30, 2026, China Isotope & Radiation Corp. holds 329.44M in cash and equivalents against 369.44M in total debt, resulting in a net debt position of 34.08M. Total book value stands at 684.92M, with working capital of 549.50M providing operational flexibility.